Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial
Dongbao Zhao(Second Military Medical University), Feng Huang(Chinese PLA General Hospital), Chunde Bao(Second Affiliated Hospital of Zhejiang University), Xing-Fu Li(Qilu Hospital of Shandong University), Lindi Jiang(Fudan University), Huaxiang Wu(Second Affiliated Hospital of Zhejiang University), Zhiyi Zhang(First Affiliated Hospital of Harbin Medical University), Zhenbiao Wu(Xijing Hospital), Yi Liu(Sichuan University), Dong Wang(Zhejiang Chinese Medical University), Liqi Bi(Jilin University), Gang Tong, Weiguo Xiao(First Hospital of China Medical University), Yang Li(Peking University), Dongyi He(Shanghai University of Traditional Chinese Medicine), Guochun Wang(China-Japan Friendship Hospital)
Cited by 6
Related Papers
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
|Neuromuscular Disorders|2019|308
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
|Cell|2024|272
Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation
|Circulation Research|2022|189